1405-9940

1405-9940

S1405-99402022000300349

10.24875/acm.21000120

México

México

México

México

México

México

México

00 09 2022

00 09 2022

92 3 349 357

1

2020 141

72

2

2012 12 Suppl 2 Suppl 2

3-10

3

2017 19 9 9

1413-5

4

2015 14 4 4

377-87

5

2017 120 9 9

1501-17

6

2015 386 9989 9989

154-62

7

2015 1 3 3

164-73

8

2015 11 4 4

228-34

9

2017 69 5 5

699-705

10

2019 74 8 8

1107-15

11

2015 184 1 1

617-22

12

2017 69 15 15

1968-82

13

2014 3 5 5

14

2016 18 5 5

665-71

15

2014 167 1 1

123-6

16

2017 7 1 1

1-8

17

2019 11 4 4

4-11

18

2020 20

11-20

19

2017 5 8 8

552-60

20

Kidney disease:improving global otucomes (KDIGO) CKD Work Group

2012 3

1-150

21

2018 138 17 17

e594

22

American Diabetes Association

2020 43 Suppl 1 Suppl 1

S14-31

23

2020 41 1 1

111-88

24

2020 56 2 2

65-7

25

Centro Nacional de Excelencia Tecnológica en Salud

2016

26

2017 136

137-61

27

2016 37 38 38

2893-962

28

2016 32 2 2

315-29

29

2019 20 2 2

123-30

30

gupo de estudio ReMeFa 2014 150 1 1

48-59

31

2014 17 1 1

24-31

32

2016 13 6 6

321-32

33

2015 16 12 12

795-801

34

2019 25 11 11

1657-66

35

2016 13 3 3

131-47

36

2016 47 3 3

895-900

37

2020 124 9 9

1406-12

38

2016 354

i4482

39

2016 68 13 13

1452-64

40

2015 68 8 8

691-9

41

2019 12 6 6

1-9

42

2017 70 5 5

854-61

43

2018 122 2 2

352-68

44

2019 10 FEB FEB

1-12

45

2016 23 6 6

621-7

46

2017 70 16 16

2022-35

47

2019 17 3 3

209-23

48

2016 23

186-91

49

2017 24 3 3

261-8

50

2019 139 8 8

1025-35

51

2019 36 4 4

321-40

52

2019 61

888-97

53

2018 60

224-32

54

2019 7 6 6

447-56

55

2018 39 44 44

3958-60

56

2020 9 19 19

1-9